ArticleJCO precision oncology2019

Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.

E Ileana Dumbrava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.